Literature DB >> 7676635

Abortive infection of Vero cells by an influenza A virus (FPV).

S C Lau1, C Scholtissek.   

Abstract

We have discovered a new type of abortive replication in Vero cells infected with fowl plague virus. In these cells there is an enhanced splicing of the colinear mRNAs of segment 7 and presumably also of segment 8, leading to an extreme overproduction of M2 and NS2 proteins. The cleavage of the hemagglutinin (HA) into HA1 and HA2 and the processing of its carbohydrate side chains are markedly retarded and incomplete. Although some of the HA is incorporated into the plasma membrane, leading to a positive hemadsorption, most of it accumulates in a discrete compartment close to the nuclear membrane, representing presumably the reticuloendothel and/or the Golgi network. Neuraminidase activity in Vero cells is extremely low. The nucleoprotein is normally released from nuclei late in infection. Very little infectious virus is released, and its spread is highly impeded.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676635     DOI: 10.1006/viro.1995.1473

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Abortive replication of influenza virus in mouse dendritic cells.

Authors:  Lisa J Ioannidis; Erin E Verity; Simon Crawford; Steven P Rockman; Lorena E Brown
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

2.  Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.

Authors:  S R Shih; R M Krug
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

Review 3.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  A DNA transfection system for generation of influenza A virus from eight plasmids.

Authors:  E Hoffmann; G Neumann; Y Kawaoka; G Hobom; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses.

Authors:  E A Govorkova; G Murti; B Meignier; C de Taisne; R G Webster
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Authors:  Sarah L Londrigan; Kirsty R Short; Joel Ma; Leah Gillespie; Steven P Rockman; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

7.  Development and characterization of swine primary respiratory epithelial cells and their susceptibility to infection by four influenza virus types.

Authors:  Chithra C Sreenivasan; Milton Thomas; Linto Antony; Tristen Wormstadt; Michael B Hildreth; Dan Wang; Ben Hause; David H Francis; Feng Li; Radhey S Kaushik
Journal:  Virology       Date:  2019-01-05       Impact factor: 3.616

8.  A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.

Authors:  Feng Wen; Lei Li; Nan Zhao; Meng-Jung Chiang; Hang Xie; Jim Cooley; Richard Webby; Peng George Wang; Xiu-Feng Wan
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

Review 9.  Cell-based influenza vaccines: progress to date.

Authors:  Jennifer M Audsley; Gregory A Tannock
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells.

Authors:  Anne Sadewasser; Katharina Paki; Katrin Eichelbaum; Boris Bogdanow; Sandra Saenger; Matthias Budt; Markus Lesch; Klaus-Peter Hinz; Andreas Herrmann; Thomas F Meyer; Alexander Karlas; Matthias Selbach; Thorsten Wolff
Journal:  Mol Cell Proteomics       Date:  2017-03-13       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.